These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 15136500

  • 1. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
    Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, Shah PK.
    Circulation; 2004 May 25; 109(20):2448-53. PubMed ID: 15136500
    [Abstract] [Full Text] [Related]

  • 2. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec 25; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 3. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
    Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, Thomas PA.
    Fundam Clin Pharmacol; 2008 Jun 25; 22(3):275-84. PubMed ID: 18485145
    [Abstract] [Full Text] [Related]

  • 4. Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein e-deficient mice.
    Pynn M, Schäfer K, Konstantinides S, Halle M.
    Circulation; 2004 Jan 27; 109(3):386-92. PubMed ID: 14699007
    [Abstract] [Full Text] [Related]

  • 5. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
    Fiorini RN, Donovan JL, Rodwell D, Evans Z, Cheng G, May HD, Milliken CE, Markowitz JS, Campbell C, Haines JK, Schmidt MG, Chavin KD.
    Liver Transpl; 2005 Mar 27; 11(3):298-308. PubMed ID: 15719408
    [Abstract] [Full Text] [Related]

  • 6. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
    Sheng R, Gu ZL, Xie ML, Zhou WX, Guo CY.
    Planta Med; 2009 Feb 27; 75(2):113-20. PubMed ID: 19096994
    [Abstract] [Full Text] [Related]

  • 7. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.
    Bodary PF, Shen Y, Vargas FB, Bi X, Ostenso KA, Gu S, Shayman JA, Eitzman DT.
    Circulation; 2005 Feb 08; 111(5):629-32. PubMed ID: 15668341
    [Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH, Moon SK.
    Arch Biochem Biophys; 2005 Mar 15; 435(2):264-72. PubMed ID: 15708369
    [Abstract] [Full Text] [Related]

  • 9. Green tea and heart health.
    Naito Y, Yoshikawa T.
    J Cardiovasc Pharmacol; 2009 Nov 15; 54(5):385-90. PubMed ID: 19668087
    [Abstract] [Full Text] [Related]

  • 10. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells.
    Asaumi H, Watanabe S, Taguchi M, Tashiro M, Nagashio Y, Nomiyama Y, Nakamura H, Otsuki M.
    Eur J Clin Invest; 2006 Feb 15; 36(2):113-22. PubMed ID: 16436093
    [Abstract] [Full Text] [Related]

  • 11. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L.
    Circulation; 2004 Feb 10; 109(5):647-55. PubMed ID: 14744975
    [Abstract] [Full Text] [Related]

  • 12. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, Rimondi E, Fabris B, Giacca M, Zauli G.
    Circulation; 2006 Oct 03; 114(14):1522-30. PubMed ID: 17000905
    [Abstract] [Full Text] [Related]

  • 13. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C.
    Cardiovasc Res; 2007 Jun 01; 74(3):537-45. PubMed ID: 17374527
    [Abstract] [Full Text] [Related]

  • 14. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
    Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M, Clergue M, Le Ricousse-Roussanne S, Barateau V, Merval R, Groux H, Tobelem G, Levy B, Tedgui A, Mallat Z.
    Circulation; 2003 Dec 09; 108(23):2839-42. PubMed ID: 14656923
    [Abstract] [Full Text] [Related]

  • 15. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 16. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
    Hishikawa K, Nakaki T, Fujita T.
    Arterioscler Thromb Vasc Biol; 2005 Feb 13; 25(2):442-6. PubMed ID: 15499038
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.
    Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, Mangeshkar P, Wong HR, Zingarelli B.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):411-7. PubMed ID: 18022615
    [Abstract] [Full Text] [Related]

  • 18. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
    't Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J.
    Circ Res; 2003 Aug 08; 93(3):262-9. PubMed ID: 12829615
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity.
    Peng PH, Ko ML, Chen CF.
    Exp Eye Res; 2008 Apr 08; 86(4):637-46. PubMed ID: 18289530
    [Abstract] [Full Text] [Related]

  • 20. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
    Sanz-González SM, Barquín L, García-Cao I, Roque M, González JM, Fuster JJ, Castells MT, Flores JM, Serrano M, Andrés V.
    Cardiovasc Res; 2007 Sep 01; 75(4):803-12. PubMed ID: 17570351
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.